Pharmaceutical Market: 10 Year Forecast 2013
Language:
Japanese
Product Code No:
C55102700
Issued In:
2013/03
#of Pages:
158
Publication Cycle:
Annual
Format:
PDF
Geographic Coverage:
Japan
Industry:
Coverage: (Product/service)
Pharmaceutical companies, pharmaceutical wholesalers, prescription drugs, generic drugs, healthcare system, hospitals and clinics
Research Target:
Manufacturers, wholesalers and governmental agencies
Research Content:
I Changing Systems in Providing Medical Services
- Revision of Medical Service Fee in 2014
- Innovative Changes of Medical Service Systems
- Future of Pharmacies in Established Separation of Dispensing and Prescribing Functions
II Pharmaceutical Wholesalers Put to the Test
- Pharmaceutical Wholesalers Trying to Escape from Grueling Campaigns
- Innovation of Pharmaceutical Wholesalers Achieved by Starting from Reform within Companies
- Future of Pharmaceutical Wholesalers
- Interview with Shuichi Watanabe, Representative Director, President and CEO of Medipal Holdings Corporation
III Pharmaceutical Industry on the Verge of Restructuring
- Crisis of Pharmaceutical Companies that Rely too much on Long-Term Articles
- Encouraging Usage of Generic Drugs Led to Increase of Generic Producers
- Enhancement to Reduce Medical Fees and Industrial Restructuring
- Changing Sales Operation at Pharmaceutical Companies
- Issues of Prescription Drug Promotion Code
IV Dramatic Changes in Competitive Landscape within Ethical Drug Market
- Pharmaceutical Companies Continue to Place Importance in Market Share
- Major Battlefield of Competition Lies in Diabetic Disease and Anticancer Drugs
- Pros and Cons for Introducing ROI
- Issue of Group Purchasing System
Estimated Production of Domestic Ethical Drugs (2012 to 2020)